(KING OF PRUSSIA, June 2026) Whether you are training for a 5K or hitting the trails for a long weekend run, your feet and ankles take on an incredible amount of stress. With 26 bones and over 100 muscles, tendons, and ligaments working together to absorb shock, even...
LATEST NEWS
Premier Orthopaedics & Philadelphia Hand to Shoulder Center are pleased to announce their Top Doctors 2026 in Philadelphia Magazine.
FOR IMMEDIATE RELEASE Premier Orthopaedics & Philadelphia Hand to Shoulder Center Philadelphia Magazine Top Doctors 2026 (KING OF PRUSSIA- APRIL 2026) Congratulations to the Premier Orthopaedics & Philadelphia Hand to Shoulder Center physicians who were named...
Honors America’s Physicians Today on National Doctors’ Day
FOR IMMEDIATE RELEASE (KING OF PRUSSIA, MARCH 2026) Today is National Doctors’ Day, a time to recognize physicians with dignity, respect, and gratitude. At Premier Orthopaedics & Philadelphia Hand to Shoulder Center, we are taking a moment to thank the doctors who...
Advancement of Orthopaedic Joint Restoration: CyborGel™ GelPlug Synthetic Cartilage Implants
Dr. Kevin Mansmann, a graduate of the Harvard Combined Orthopaedic Surgery Program coupled with a Fellowship in Total Joint Replacements, has identified a treatment gap for end stage arthritis. Dr. Mansmann an Orthopaedic Surgeon at Premier Orthopaedics in Malvern and U.S Ski Team Physician for fifteen years, specializes in Arthroscopic & Total Joint Replacement surgery.
Dr. Mansmann has been researching minimally invasive total joint replacement and “Arthroscopic Joint Resurfacing”. The use of CyborGel™ as a synthetic cartilage represents a potential Arthroscopic solution to treat arthritis end stage joint damage that reproduces the microanatomy of hyaline joint cartilage and the anchor duplicates the structure of bone, for secure bone fixation, healing and union. In these innovative minimally invasive “Arthroscopic Surgeries”, the CyborGelTM implants are engineered to “resurface” the damaged cartilage gliding surfaces.
Testing is currently underway for a meeting with the FDA to review these promising results in early 2018. Dr. Mansmann states “CyborGel™ implants have revolutionary and transformative potential as a less invasive “pre-total joint replacement”, clinical treatment option, that utilizes instrumentation for arthroscopic installation, to minimize pain and optimize a speedy recovery. “The clinical application being end stage arthritis joint damage, before bone deformity, earlier in the disease process, thereby, reducing the need for total joint replacement surgery”.
Dr. Mansmann is the Founder and Director of the Arthroscopy Research Institute and the AJR Foundation. Joining Premier Orthopaedics in 2015, Dr. Mansmann brings with him the most innovative and advanced technologies in both surgical and non-surgical care, in addition to the classical techniques.
Kevin Mansmann, M.D.